02
Oct
2023
16:30
BST
17:30
CEST
11:30
EST
Webinar
What’s New in the European ACS Guidelines and How Will My Practice Change?
-
Views:
11017
-
Likes:
32
Overview
This live roundtable discussion, chaired by Prof Robert Storey (University of Sheffield, Sheffield, UK), addresses the 2023 ACS guideline updates that were recently presented at the European Society of Cardiology (ESC) annual meeting in Amsterdam.
The panel of experts; Dr Dominick Angiolillo (University of Florida, Gainesville, US), Dr Christopher Cannon (Brigham and Women's Hospital, Boston, US), Prof Pascal Vranckx (Heart Centre Hasselt, Hasselt, BE) and Prof Stefan James (Uppsala University, Uppsala, SE) will discuss the new recommendations in-depth and provide commentary on their application to daily practice. They will also be compared with other existing guidance, including those issued by the American societies.
A unique facet to this event is the ability for our live viewers to pose questions to our faculty when registering for the event, or during the broadcast. This is your chance to gain the perspective from an expert panel – many of whom were involved in developing or reviewing the guideline recommendations.
Register today, and please submit any questions that you have for our panel in advance.
Faculty:
Robert F Storey
Dominick J Angiolillo
Christopher P Cannon
Pascal Vranckx
Stefan James
This programme is supported by an unrestricted educational grant from AstraZeneca.
Agenda
Key Learning Objectives
- Summarise major updates to European guidance on the use of antithrombotic agents in ACS patients
- Recall clinical evidence underlining recent updates to European guidance on the use of antithrombotic agents
- Compare the recent European guidance for the treatment of ACS with other existing guidance
- Apply new recommendations around the use of antithrombotic agents in daily practice
Target Audience
- Cardiologists
- Interventional Cardiologists
- Primary Care Physicians
- Nurses, Pharmacists
- Other Applied HCPs
Faculty Biographies
Dominick J Angiolillo
Dr Dominick Angiolillo graduated from the Catholic University of the Sacred Heart Medical School in Rome, Italy and pursued training in interventional cardiology at the Complutense University of Madrid in Spain and received his Ph.D. in cellular and molecular cardiology. Dr Angiolillo is board-certified in internal medicine, cardiovascular disease and interventional cardiology.
In 2004, Dr Angiolillo joined the University of Florida College of Medicine in Jacksonville, where he is a professor of medicine, director of cardiovascular research and director of the interventional cardiology fellowship program.
Dr Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as cardiovascular medicine textbooks. He has authored more than 400 peer-reviewed articles, with nearly 30,000 citations and an H-index of 86. He has authored more than 30 book chapters and is the editor of his own textbook on antithrombotic medicine.
Dr Dominick Angiolillo is on the Editorial Board of European Cardiology Review.
Christopher P Cannon
Dr Christopher Cannon is a Professor of Medicine at Harvard Medical School, and Senior Physician in the Preventive Cardiology section of the Cardiovascular Division at Brigham and Women’s Hospital.
He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center, and cardiovascular fellowship at Brigham and Women’s Hospital.
Dr Cannon has published over 1000 original articles, reviews or book chapters in the field of acute coronary syndromes and prevention and has authored or edited 18 books. He has received numerous awards, including leadership awards from the American College of Cardiology, American Heart Association and National Lipid Association.
He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18, PROVE IT, IMPROVE IT, RE-DUAL PCI and VERTIS CV trials.
Dr Cannon is on the Editorial Board of European Cardiology Review.
Pascal Vranckx
Prof Pascal Vranckx is a Clinical Consultant in Interventional Cardiology and Medical Director of Cardiac Critical Care Services at the Hartcentrum Hasselt in Belgium, and Professor of Medicine at the University of Hasselt, Belgium.
Prof Vranckx is also board member of the European Cardiovascular Research Institute, in Rotterdam, The Netherlands.
Stefan James
Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.
He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has previously held positions at the Karolinska Hospital, the University Hospital Örebro and Duke Clinical Research Institute, Duke University.
Robert F Storey
Prof Robert Storey is Academic Director and an honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He is Professor of Cardiology at the University of Sheffield, UK, where he has headed a platelet research group since 2002 within the Department of Cardiovascular Science.
He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention. He served as a member of the executive committees for the PLATO and PEGASUS studies, leading the platelet function substudies for these trials, and of the steering committee for the TRA-CER, EPICOR and ATLANTIC studies. He is currently a member of the steering committee for the COMPLETE study. He was Chair of the Working Group on Thrombosis of the European Society of Cardiology (ESC) from 2012-2014 and has been a Task Force member for several ESC guidelines on non-ST-elevation acute coronary syndromes and dyslipidaemias.